RBMX and thyroid tumor: Interestingly, we found two independent de novo mutations in the RBM gene family (i.e. RBM10 and RBMX) in the vemurafenib-resistant cells but not in the vemurafenib-naïve thyroid tumor cells which did not show measurable allelic fractions for these mutations.